Redeye Feed

2026-11-06 16:24:00 Enviro: First paid step towards a North American licence

2026-11-06 16:22:00 Xspray Pharma: Raising cash and ongoing inspection of manufacturing facilities

2026-11-06 16:15:00 BioInvent: Fair Value Adjusted for Rights Issue Terms

2026-11-06 16:14:00 Xbrane Biopharma (Q3 review): Approval secured

2026-11-06 16:13:00 G5 Entertainment (Q3 Review): Leaner cost base, growth levers taking shape

2026-11-06 16:12:00 NextCell Pharma: Updating our view post the trial readout

2026-11-06 16:11:00 Freemelt: Securing financing until break-even

2026-11-06 16:10:00 Smoltek (Q3 Review): Setting the stage for 2027

2026-11-06 16:10:00 Catella (Q3 Review): Swimming against the tide

2026-11-06 16:09:00 CombinedX (Q3 Review): ERP Core Takes Shape, Margin Recovery Still Ahead

2026-11-05 18:40:00 GomSpace (Q3 Review): New 2030 targets support our positive long-term view

2026-11-05 18:39:00 Active Biotech (Q3 Review): Phase II Dose in Q1, Efficacy Data in H2 2027

2026-11-05 18:38:00 Boreo (Q3 review): Operating leverage at last

2026-11-05 18:37:00 Relais (Q3 review): Earnings beat, Technical Wholesale lags

2026-11-05 18:36:00 Senzime: Broadened use of TetraGraph in electroconvulsive therapy

2026-11-05 12:17:00 Embracer (Q2 Preview): Hobbit lifts Fellowship in Q2, pipeline drives H2 upside

2026-11-05 12:16:00 Xplora (Q3 Preview): First Emporia quarter, and a store count to show

2026-11-05 12:15:00 4C Group (Q3 Review): Bruised but not beaten

2026-11-05 12:14:00 Cheffelo (Q3 Review): Don’t Judge the Dish by the Plating

2026-11-05 12:13:00 Corline Biomedical: Globe adoption takes a more gradual path

2026-11-05 12:12:00 Absolent (Q3 Review): Margins up, growth took a breather

2026-11-04 17:56:00 Cantargia: Early Haematology Signal Ahead of ASH Oral

2026-11-04 17:55:00 Intervacc (Q3 Preview): Focus on upcoming catalysts

2026-11-04 17:54:00 Freja eID: Teracom framework agreement opens up to SEK27.9m in ARR, far beyond our assumptions

2026-11-04 17:53:00 Magle Group: Preliminary Q3 figures ahead of delisting

2026-11-04 11:04:00 RaySearch Laboratories (Q4 Review): Strong Q4 needed to restore confidence

2026-11-04 11:02:00 Truecaller (Q3 Review): Selloff overdone – revenue growth beats user slowdown

2026-11-04 11:01:00 Hacksaw (Q3 Review): Uncertain timing of growth recovery

2026-11-04 11:00:00 NYORDA (Q3 Review): Broad-Based Growth at Single-Digit Multiples

2026-11-03 16:43:00 INQ Group: Foreign capital at improved terms, and more deals guided for Q4

2026-11-03 16:42:00 Fable Media Group: Comment on guidance adjustment

2026-11-03 16:41:00 I-Tech: EU vote as expected

2026-11-03 16:40:00 Genovis (Q3 preview): Expecting a solid release

2026-11-03 16:39:00 CombinedX: Enqore sold at 10x EBITA and further AI investment

2026-11-03 16:38:00 Freemelt: Rights issue of ~SEK 152m

2026-11-03 13:31:00 Weekly Edge Case – Bonesupport

2026-11-03 11:08:00 Moberg Pharma: Moberg Pharma: U.S. patent extends IP runway to end of 2041

2026-11-03 11:07:00 Lytix Biopharma: NeoLIPA hits primary endpoint

2026-11-03 11:06:00 Invisio (Q3 Review): Strong order intake supports a solid year-end

2026-11-03 11:05:00 Freemelt (Q3 Preview): Building the order backlog

2026-11-03 11:04:00 Smart Eye (Q3 Preview): Summer seasonality mid EU ramp

2026-11-02 14:16:00 Alligator Bioscience: Mitazalimab sold to Biossil

2026-11-02 14:14:00 Paxman: First CIPN order

2026-11-02 14:13:00 CTEK (Q3 Review): Back to growth, margins keep surprising

2026-11-02 14:12:00 Indutrade (Q3 review): Orders keep building

2026-10-30 14:16:00 Enviro (Q3 Review): Reconstruction enters its final phase

2026-10-30 14:15:00 Transtema (Q3 Preliminary): Sweden solid, Norway sees significant decline and is written down

2026-10-30 14:14:00 CLS: Industry partner in NCI-funded programme for spinal metastases

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode